For the overall group analysis, patients in Groups 1 and 2 displayed similar expression patterns, particularly the downregulation of cancer-associated genes (Fas, NOS2, VEGF-A, NR4A3, MKi67, and EpCAM), as well as the pro-inflammatory cytokine IL-6. This evidence concerns the gene NR4A3 and cancer.